ArticleJournal of nanobiotechnology2026

A novel CLDN6 nanobody-based bispecific T-cell engager delivered by self-amplifying RNA platform exhibits potent antitumor efficacy.

Zhixiong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.